Literature DB >> 29393221

The Synergy of Endotoxin and (1→3)-β-D-Glucan, from Gut Translocation, Worsens Sepsis Severity in a Lupus Model of Fc Gamma Receptor IIb-Deficient Mice.

Jiraphorn Issara-Amphorn, Saowapha Surawut, Navaporn Worasilchai, Arthid Thim-Uam, Malcolm Finkelman, Ariya Chindamporn, Tanapat Palaga, Nattiya Hirankarn, Prapaporn Pisitkun, Asada Leelahavanichkul.   

Abstract

We investigated the influence of spontaneous gut leakage upon polymicrobial sepsis in a lupus model with Fc gamma receptor IIb-deficient (FcGRIIb-/-) mice aged 8 and 40 weeks, as representing asymptomatic and symptomatic lupus, respectively. Spontaneous gut leakage, determined by (i) the presence of FITC-dextran, (ii) elevated serum endotoxin, and (iii) elevated serum (1→3)-β-D-glucan (BG), was demonstrated in symptomatic lupus but not in the asymptomatic group. In parallel, spontaneous gut leakage, detected by elevated serum BG without fungal infection, was demonstrated in patients with active lupus nephritis. Gut leakage induced by dextran sulfate solution (DSS) or endotoxin administration together with BG or endotoxin alone, but not BG alone, enhanced the severity of cecal ligation and puncture (CLP) sepsis more prominently in 8-week-old FcGRIIb-/- mice. Additionally, the bone marrow-derived macrophages of FcGRIIb-/- mice produced higher cytokine levels when coexposed to endotoxin and BG, when compared to wild-type mice. In summary, spontaneous gut leakage was demonstrated in symptomatic FcGRIIb-/- mice and the induction of gut permeability worsened sepsis severity. Gut translocation of endotoxin and BG had a minor effect on wild-type mice, but the synergistic effect of BG and endotoxin was prominent in FcGRIIb-/- mice. The data suggest that therapeutic strategies addressing gut leakage may be of interest in sepsis conditions in patients with lupus.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  (1→3)-β-D-glucan; Endogenous endotoxin; FcGRIIb-deficient mice; Sepsis severity; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 29393221      PMCID: PMC6757155          DOI: 10.1159/000486321

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  31 in total

1.  OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS.

Authors:  M W ROPES
Journal:  Medicine (Baltimore)       Date:  1964-05       Impact factor: 1.889

Review 2.  Alterations in intestinal permeability.

Authors:  M C Arrieta; L Bistritz; J B Meddings
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 3.  Infections and SLE.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Autoimmunity       Date:  2005-11       Impact factor: 2.815

4.  The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood.

Authors:  Charlotte Sissener Engstad; Rolf Einar Engstad; Jan-Ole Olsen; Bjarne Osterud
Journal:  Int Immunopharmacol       Date:  2002-10       Impact factor: 4.932

5.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

6.  CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.

Authors:  M Mihara; I Tan; Y Chuzhin; B Reddy; L Budhai; A Holzer; Y Gu; A Davidson
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 7.  Role of Fc gamma receptor IIb polymorphism in the genetic background of systemic lupus erythematosus: insights from Asia.

Authors:  Naoyuki Tsuchiya; Chieko Kyogoku
Journal:  Autoimmunity       Date:  2005-08       Impact factor: 2.815

8.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

Review 9.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

10.  Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice.

Authors:  Silvia Bolland; Young-Sun Yim; Katalin Tus; Edward K Wakeland; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  29 in total

1.  Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34.

Authors:  Wimonrat Panpetch; Pratsanee Hiengrach; Sumanee Nilgate; Somying Tumwasorn; Naraporn Somboonna; Alisa Wilantho; Piraya Chatthanathon; Piyapan Prueksapanich; Asada Leelahavanichkul
Journal:  Gut Microbes       Date:  2019-09-18

2.  A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.

Authors:  Elizabeth Ogunrinde; Zejun Zhou; Zhenwu Luo; Alexander Alekseyenko; Quan-Zhen Li; Danielle Macedo; Diane L Kamen; Jim C Oates; Gary S Gilkeson; Wei Jiang
Journal:  Arthritis Rheumatol       Date:  2019-09-27       Impact factor: 10.995

3.  Serious, Severe, Sepsis.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2020-01-31       Impact factor: 7.349

Review 4.  Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis.

Authors:  Panomwat Amornphimoltham; Peter S T Yuen; Robert A Star; Asada Leelahavanichkul
Journal:  Dig Dis Sci       Date:  2019-03-13       Impact factor: 3.199

Review 5.  Loss of Gut Barrier Integrity In Lupus.

Authors:  Longhuan Ma; Laurence Morel
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

6.  A Synergy Between Endotoxin and (1→3)-Beta-D-Glucan Enhanced Neutrophil Extracellular Traps in Candida Administered Dextran Sulfate Solution Induced Colitis in FcGRIIB-/- Lupus Mice, an Impact of Intestinal Fungi in Lupus.

Authors:  Supichcha Saithong; Wilasinee Saisorn; Peerapat Visitchanakun; Kritsanawan Sae-Khow; Direkrit Chiewchengchol; Asada Leelahavanichkul
Journal:  J Inflamm Res       Date:  2021-06-01

Review 7.  Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.

Authors:  Rayoun Ramendra; Stéphane Isnard; Vikram Mehraj; Jun Chen; Yonglong Zhang; Malcolm Finkelman; Jean-Pierre Routy
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

8.  Glucan rich nutrition does not increase gut translocation of beta-glucan.

Authors:  Martin Hoenigl; John Lin; Malcolm Finkelman; Yonglong Zhang; Maile Y Karris; Scott L Letendre; Ronald J Ellis; Leah Burke; Byron Richard; Thaidra Gaufin; Stéphane Isnard; Jean-Pierre Routy; Sara Gianella
Journal:  Mycoses       Date:  2020-11-21       Impact factor: 4.377

9.  Candida Administration in Bilateral Nephrectomy Mice Elevates Serum (1→3)-β-D-glucan That Enhances Systemic Inflammation Through Energy Augmentation in Macrophages.

Authors:  Jiraphorn Issara-Amphorn; Cong Phi Dang; Wilasinee Saisorn; Kavee Limbutara; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

10.  Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.

Authors:  Wilasinee Saisorn; Supichcha Saithong; Pornpimol Phuengmaung; Kanyarat Udompornpitak; Thansita Bhunyakarnjanarat; Peerapat Visitchanakun; Awirut Chareonsappakit; Prapaporn Pisitkun; Direkrit Chiewchengchol; Asada Leelahavanichkul
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.